Showing 421 - 440 results of 646 for search '"metabolic syndrome"', query time: 0.06s Refine Results
  1. 421

    Effect of Red Wine Consumption on Serum Oxidation and Adiponectin Levels in Overweight and Healthy Individuals by Karadeniz Muammer, Akçay Yasemin D., Yıldırım Hatice K., Yılmaz Candeğer, Sözmen Eser Y.

    Published 2014-09-01
    “…Obesity is a well-known independent risk factor for CVD and metabolic syndrome. It has been shown that moderate red wine consumption might reduce the risk of cardiovascular disease (CVD). …”
    Get full text
    Article
  2. 422

    A Review of the Potential for Cardiometabolic Dysfunction in Youth with Spina Bifida and the Role for Physical Activity and Structured Exercise by Kevin R. Short, Dominic Frimberger

    Published 2012-01-01
    “…Children and adolescents who have decreased mobility due to spina bifida may be at increased risk for the components of metabolic syndrome, including abdominal obesity, insulin resistance, and dyslipidemia due to low physical activity. …”
    Get full text
    Article
  3. 423

    NAFLD, Estrogens, and Physical Exercise: The Animal Model by Jean-Marc Lavoie, Abdolnaser Pighon

    Published 2012-01-01
    “…At the present time, weight loss and exercise are regarded as first line treatments for NAFLD in postmenopausal women, as it is the case for the management of metabolic syndrome. In recent years, there has been substantial evidence coming mostly from the use of the animal model, that indeed estrogens withdrawal is associated with modifications of molecular markers favouring the activity of metabolic pathways ultimately leading to liver fat accumulation. …”
    Get full text
    Article
  4. 424

    Testosterone Deficiency, Cardiac Health, and Older Men by G. Hackett, M. Kirby, A. J. Sinclair

    Published 2014-01-01
    “…Screening for low testosterone is recommended in a number of high risk groups including those with type 2 diabetes and metabolic syndrome. There are recent data to suggest that testosterone replacement therapy may reduce cardiovascular mortality as well as improving multiple surrogate markers for cardiovascular events. …”
    Get full text
    Article
  5. 425

    Research Progress in Bioactive Components and Health Benefits of Red Raspberry by SUN Huajun, CUI Fangzheng, LIU Ying, ZHU Sijing, LI Yue

    Published 2025-01-01
    “…This paper comprehensively reviews the nutrient composition and content of red raspberry as a function of variety, harvest time and part, and it systematically summarizes health benefits of different parts of red raspberry such as antioxidant, anti-inflammatory, antibacterial, anti-cancer, and metabolic syndrome-alleviating functions as well as their mechanisms of action and application. …”
    Get full text
    Article
  6. 426
  7. 427

    Association between the composite dietary antioxidant index and non-alcoholic fatty liver disease: evidence from National Health and Nutrition Examination Survey 2005–2016 by Yidian Fu, Yidian Fu, Chao Jiang, Zonglin Li, Xiangyun Shi, Peiyuan Lv, Peiyuan Lv, Jingbo Zhang

    Published 2025-01-01
    “…In subgroup analyses, CDAI was inversely associated with NAFLD among participants with a BMI <25 (OR, 0.89; 95% CI, 0.83–0.95) and without metabolic syndrome (OR, 0.93; 95% CI, 0.91–0.96). The interaction tests revealed significant differences in these subgroups (P for interaction = 0.04 for BMI and 0.003 for metabolic syndrome). …”
    Get full text
    Article
  8. 428

    Traditional and Non-Traditional Risk Factors of Acute Coronary Syndrome in Young Women: Evidence from the ANCORS-YW Study by Ibdah R, Al-Nusair M, Abuhalimeh R, Mahmoud SA, Laswi B, Rawashdeh S, Hamoudeh A, Kheirallah KA

    Published 2025-01-01
    “…The ACS group, compared to control group, had higher proportions of type-2 diabetes (41.6%vs.11.7%, p< 0.001), hypertension (53.9%vs.23.4%, p< 0.001), tobacco use (37.7%vs.24.2%, p=0.001), family history of cardiovascular disease (53.2%vs.23.4%, p< 0.001), metabolic syndrome (14.3%vs.2.4%, p< 0.001), and preterm delivery (24.7%vs.16.7%, p=0.032). …”
    Get full text
    Article
  9. 429

    Potential Synergies of β-Hydroxybutyrate and Butyrate on the Modulation of Metabolism, Inflammation, Cognition, and General Health by Franco Cavaleri, Emran Bashar

    Published 2018-01-01
    “…The low-carbohydrate high-fat diet (LCHFD), also known as the ketogenic diet, has cycled in and out of popularity for decades as a therapeutic program to treat metabolic syndrome, weight mismanagement, and drug-resistant disorders as complex as epilepsy, cancer, dementia, and depression. …”
    Get full text
    Article
  10. 430

    Diabetes in HFE Hemochromatosis by James C. Barton, Ronald T. Acton

    Published 2017-01-01
    “…Increased type 2 diabetes risk in HFE hemochromatosis is associated with one or more factors, including abnormal iron homeostasis and iron overload, decreased insulin secretion, cirrhosis, diabetes in first-degree relatives, increased body mass index, insulin resistance, and metabolic syndrome. In p.C282Y homozygotes, serum ferritin, usually elevated at hemochromatosis diagnosis, largely reflects body iron stores but not diabetes risk. …”
    Get full text
    Article
  11. 431

    Sugar-Sweetened Beverage Intake Trends in US Adolescents and Their Association with Insulin Resistance-Related Parameters by Andrew A. Bremer, Peggy Auinger, Robert S. Byrd

    Published 2010-01-01
    “…Factors other than SSB consumption must therefore be contributing to the increasing prevalence of obesity and metabolic syndrome in the majority of US children.…”
    Get full text
    Article
  12. 432

    MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives by Michael Karin, Ju Youn Kim

    Published 2025-02-01
    “…The obesogenic environment fosters a positive energy balance and results in a continuous rise of obesity and metabolic syndrome. However, it is difficult to understand how metabolic complications lead to the poor prognosis of liver diseases and which molecular mechanisms are underpinning MAFLD‐driven HCC development. …”
    Get full text
    Article
  13. 433

    AzioInositols in the Treatment of Insulin-Mediated Diseases by Giovanna Muscogiuri, Stefano Palomba, Antonio Simone Laganà, Francesco Orio

    Published 2016-01-01
    “…Thus, the aim of this review is to provide current evidence on the potential benefits of inositol isomers (MYO-INS and DCI) in the treatment of disease associated to insulin resistance such as polycystic ovary syndrome (PCOS), gestational diabetes, and metabolic syndrome. Finally, molecular insights into inositol insulin-sensitizing effects will be covered focusing on the possible role of inositol glycans as insulin second messengers.…”
    Get full text
    Article
  14. 434

    Ultra Processed Food Addiction among People: A Mini-Review of the Evidence by Mahsa Rezazadegan, Reza Amani

    Published 2025-02-01
    “…Food addiction is important for a better understanding of psychiatric and medical problems such as eating disorders, obesity, and metabolic syndrome. Methods: In this mini-review, we will examine food addiction and the appropriate strategies for its management. …”
    Get full text
    Article
  15. 435

    Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease by Sara Jarmakiewicz-Czaja, Aneta Sokal, Piotr Pardak, Rafał Filip

    Published 2022-01-01
    “…Recent data also indicate a frequent coexistence of metabolic syndrome in this group of patients. Certain groups of drugs also increase the risk of developing inflammation, liver fibrosis, and cirrhosis. …”
    Get full text
    Article
  16. 436

    A Rare Case of Metastatic Hepatocellular Carcinoma Masquerading as a Forehead Hematoma by Kimberly Sanders, Ashley Thomas, Carmen Isache, Anwer Siddiqi

    Published 2020-01-01
    “…With increasing rates of metabolic syndrome and obesity, it is not surprising that NASH is quickly becoming a leading cause of chronic liver disease and HCC in the western hemisphere (Wang and Malhi, 2018). …”
    Get full text
    Article
  17. 437

    Cardiovascular Risk Factors in the Antiphospholipid Syndrome by Felipe Freire da Silva, Roger Abramino Levy, Jozélio Freire de Carvalho

    Published 2014-01-01
    “…The influence of nontraditional risk factors as hyperhomocysteinemia, increased lipoprotein a, and anti-oxLDL in the development of thromboembolic events in APS patients has been studied in scientific literature. Metabolic syndrome with all its components also has been recently studied in antiphospholipid syndrome and is associated with arterial events.…”
    Get full text
    Article
  18. 438

    The Association of Adiposity Indices and Plasma Vitamin D in Young Females in Saudi Arabia by Lubna Ibrahim Al Asoom

    Published 2016-01-01
    “…Some evidences indicate its association with metabolic syndrome, type II diabetes, and cardiovascular diseases. …”
    Get full text
    Article
  19. 439

    Nonconvulsive Status Epilepticus Complicating Epstein-Barr Virus Encephalitis in a Child by Filippo Greco, Maria Donatella Cocuzza, Pierluigi Smilari, Giovanni Sorge, Lorenzo Pavone

    Published 2014-01-01
    “…Pediatric NCSE is a heterogeneous clinical entity with poor outcome and different etiologies, including central nervous system infection, stroke, toxic-metabolic syndrome, and epileptic syndrome. We report a 4-year-old girl with seizure and behavioral changes in whom the analysis of cerebrospinal fluid by polymerase chain reaction was positive for Epstein-Barr virus. …”
    Get full text
    Article
  20. 440

    Cardiorespiratory Fitness, Metabolic Risk, and Inflammation in Children by Antonios D. Christodoulos, Helen T. Douda, Savvas P. Tokmakidis

    Published 2012-01-01
    “…The aim of this study was to investigate the independent associations among cardiorespiratory fitness, metabolic syndrome (MetS), and C-reactive protein (CRP) in children. …”
    Get full text
    Article